Headline
The latest stories from AHA Today.
The Illinois Supreme Court today unanimously upheld the state’s hospital property tax exemption law, rejecting the plaintiff’s argument that the statute was unconstitutional because it failed to expressly mention the constitutional requirements for exemption.
The AHA today hosted a forum in Los Angeles in which hospital and health system leaders from across the country shared strategies their organizations are undertaking to make health care more affordable.
More than 100 organizations, including the AHA, yesterday urged House and Senate leaders to include the Overdose Prevention and Patient Safety Act (H.R. 6082) in the final agreement on opioid legislation.
The Department of Health and Human Services this week awarded more than $1 billion in grants to help combat the opioid crisis.
Opioid-related hospital stays and emergency department visits for patients 65 and older increased 54 percent and 100 percent, respectively, between 2010 and 2015.
The Food and Drug Administration yesterday updated its Risk Evaluation and Mitigation Strategy for extended-release and long-acting opioid analgesics, and extended the same requirements to immediate-release opioid analgesic products.
The North Carolina Hospital Foundation, a 501(c)(3) affiliate of the NC Healthcare Association, has established a disaster relief fund to support North Carolina health care workers who suffered significant property loss to their homes during Hurricane Florence and the subsequent flooding.
The Senate today voted 93-7 to pass legislation that would provide $178.1 billion in discretionary funding for the departments of Defense, Labor, Health and Human Services, and Education in fiscal year 2019 and extend current funding levels for other federal programs until Dec. 7.
President Trump today announced a National Biodefense Strategy to “more effectively prepare for and combat biological threats.”
The Senate last night voted 98-2 to approve the Patient Right to Know Drug Prices Act (S. 2554), a bill that would prohibit private health plans from restricting a pharmacist’s ability to inform enrollees when a drug would cost less without using their insurance.